Board of Directors

Promethera® Biosciences is strategically advised by a distinguished international board of directors to drive us towards our goal of being the global leader in innovative cell therapies for liver diseases.

Etienne Sokal – MD, PhD

Founder
Senior Scientific & Medical Advisor
Chairman of the SMAB & the Board of Directors

Reiko Namikawa – MD, PhD

Director

Edward Haack

Director
Chairman of the Audit Committee
Itochu Corporation

Shintaro Hayashi

Director
Co-High

Alick Dong

Director
Hao Tian

Chi Tak Fok

Director
AQ Invest SPRL

Alain Parthoens

Director
New Life Science

Tetsuya Kurihara

Observer
IGF

Costantino Mariella

Observer